Literature DB >> 24149839

MS/MS-based networking and peptidogenomics guided genome mining revealed the stenothricin gene cluster in Streptomyces roseosporus.

Wei-Ting Liu1, Anne Lamsa2, Weng Ruh Wong3, Paul D Boudreau4, Roland Kersten4, Yao Peng1, Wilna J Moree5, Brendan M Duggan5, Bradley S Moore4, William H Gerwick4, Roger G Linington3, Kit Pogliano2, Pieter C Dorrestein6.   

Abstract

Most (75%) of the anti-infectives that save countless lives and enormously improve quality of life originate from microbes found in nature. Herein, we described a global visualization of the detectable molecules produced from a single microorganism, which we define as the 'molecular network' of that organism, followed by studies to characterize the cellular effects of antibacterial molecules. We demonstrate that Streptomyces roseosporus produces at least four non-ribosomal peptide synthetase-derived molecular families and their gene subnetworks (daptomycin, arylomycin, napsamycin and stenothricin) were identified with different modes of action. A number of previously unreported analogs involving truncation, glycosylation, hydrolysis and biosynthetic intermediates and/or shunt products were also captured and visualized by creation of a map through MS/MS networking. The diversity of antibacterial compounds produced by S. roseosporus highlights the importance of developing new approaches to characterize the molecular capacity of an organism in a more global manner. This allows one to more deeply interrogate the biosynthetic capacities of microorganisms with the goal to streamline the discovery pipeline for biotechnological applications in agriculture and medicine. This is a contribution to a special issue to honor Chris Walsh's amazing career.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24149839      PMCID: PMC3919142          DOI: 10.1038/ja.2013.99

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  41 in total

1.  The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases.

Authors:  T Stachelhaus; H D Mootz; M A Marahiel
Journal:  Chem Biol       Date:  1999-08

Review 2.  Mass spectrometry-based proteomics.

Authors:  Ruedi Aebersold; Matthias Mann
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

Review 3.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

4.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 5.  Where will new antibiotics come from?

Authors:  Christopher Walsh
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

6.  [Metabolic products of microorganisms. 134. Stenothricin, a new inhibitor of the bacterial cell wall synthesis (author's transl)].

Authors:  A Hasenböhler; H Kneifel; W A König; H Zähner; H J Zeiler
Journal:  Arch Microbiol       Date:  1974       Impact factor: 2.552

7.  A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation.

Authors:  M Debono; M Barnhart; C B Carrell; J A Hoffmann; J L Occolowitz; B J Abbott; D S Fukuda; R L Hamill; K Biemann; W C Herlihy
Journal:  J Antibiot (Tokyo)       Date:  1987-06       Impact factor: 2.649

8.  Crystallographic and biophysical analysis of a bacterial signal peptidase in complex with a lipopeptide-based inhibitor.

Authors:  Mark Paetzel; Jonathon J Goodall; Malgosia Kania; Ross E Dalbey; Malcolm G P Page
Journal:  J Biol Chem       Date:  2004-05-10       Impact factor: 5.157

9.  Isolation, structural characterization, and properties of mattacin (polymyxin M), a cyclic peptide antibiotic produced by Paenibacillus kobensis M.

Authors:  Nathaniel I Martin; Haijing Hu; Matthew M Moake; John J Churey; Randy Whittal; Randy W Worobo; John C Vederas
Journal:  J Biol Chem       Date:  2003-02-04       Impact factor: 5.157

10.  Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tü 6075. II. Structure elucidation.

Authors:  Alexandra Höltzel; Dietmar G Schmid; Graeme J Nicholson; Stefan Stevanovic; Judith Schimana; Klaus Gebhardt; Hans-Peter Fiedler; Günther Jung
Journal:  J Antibiot (Tokyo)       Date:  2002-06       Impact factor: 2.649

View more
  28 in total

1.  Emerging mass spectrometry techniques for the direct analysis of microbial colonies.

Authors:  Jinshu Fang; Pieter C Dorrestein
Journal:  Curr Opin Microbiol       Date:  2014-07-26       Impact factor: 7.934

2.  Mapping Microbial Response Metabolomes for Induced Natural Product Discovery.

Authors:  Dagmara K Derewacz; Brett C Covington; John A McLean; Brian O Bachmann
Journal:  ACS Chem Biol       Date:  2015-06-17       Impact factor: 5.100

Review 3.  Mass spectrometry tools and workflows for revealing microbial chemistry.

Authors:  Tal Luzzatto-Knaan; Alexey V Melnik; Pieter C Dorrestein
Journal:  Analyst       Date:  2015-08-07       Impact factor: 4.616

4.  Winners of the 2015 JA Medals for excellence.

Authors:  Minoru Yoshida
Journal:  J Antibiot (Tokyo)       Date:  2016-09       Impact factor: 2.649

5.  Molecular networking and pattern-based genome mining improves discovery of biosynthetic gene clusters and their products from Salinispora species.

Authors:  Katherine R Duncan; Max Crüsemann; Anna Lechner; Anindita Sarkar; Jie Li; Nadine Ziemert; Mingxun Wang; Nuno Bandeira; Bradley S Moore; Pieter C Dorrestein; Paul R Jensen
Journal:  Chem Biol       Date:  2015-04-09

Review 6.  Genome Mining as New Challenge in Natural Products Discovery.

Authors:  Luisa Albarano; Roberta Esposito; Nadia Ruocco; Maria Costantini
Journal:  Mar Drugs       Date:  2020-04-09       Impact factor: 5.118

Review 7.  Symbiosis-inspired approaches to antibiotic discovery.

Authors:  Navid Adnani; Scott R Rajski; Tim S Bugni
Journal:  Nat Prod Rep       Date:  2017-07-06       Impact factor: 13.423

Review 8.  Mass spectrometry of natural products: current, emerging and future technologies.

Authors:  Amina Bouslimani; Laura M Sanchez; Neha Garg; Pieter C Dorrestein
Journal:  Nat Prod Rep       Date:  2014-05-07       Impact factor: 13.423

9.  Rapid Inhibition Profiling in Bacillus subtilis to Identify the Mechanism of Action of New Antimicrobials.

Authors:  Anne Lamsa; Javier Lopez-Garrido; Diana Quach; Eammon P Riley; Joe Pogliano; Kit Pogliano
Journal:  ACS Chem Biol       Date:  2016-06-14       Impact factor: 5.100

10.  Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking.

Authors:  Mingxun Wang; Jeremy J Carver; Vanessa V Phelan; Laura M Sanchez; Neha Garg; Yao Peng; Don Duy Nguyen; Jeramie Watrous; Clifford A Kapono; Tal Luzzatto-Knaan; Carla Porto; Amina Bouslimani; Alexey V Melnik; Michael J Meehan; Wei-Ting Liu; Max Crüsemann; Paul D Boudreau; Eduardo Esquenazi; Mario Sandoval-Calderón; Roland D Kersten; Laura A Pace; Robert A Quinn; Katherine R Duncan; Cheng-Chih Hsu; Dimitrios J Floros; Ronnie G Gavilan; Karin Kleigrewe; Trent Northen; Rachel J Dutton; Delphine Parrot; Erin E Carlson; Bertrand Aigle; Charlotte F Michelsen; Lars Jelsbak; Christian Sohlenkamp; Pavel Pevzner; Anna Edlund; Jeffrey McLean; Jörn Piel; Brian T Murphy; Lena Gerwick; Chih-Chuang Liaw; Yu-Liang Yang; Hans-Ulrich Humpf; Maria Maansson; Robert A Keyzers; Amy C Sims; Andrew R Johnson; Ashley M Sidebottom; Brian E Sedio; Andreas Klitgaard; Charles B Larson; Cristopher A Boya P; Daniel Torres-Mendoza; David J Gonzalez; Denise B Silva; Lucas M Marques; Daniel P Demarque; Egle Pociute; Ellis C O'Neill; Enora Briand; Eric J N Helfrich; Eve A Granatosky; Evgenia Glukhov; Florian Ryffel; Hailey Houson; Hosein Mohimani; Jenan J Kharbush; Yi Zeng; Julia A Vorholt; Kenji L Kurita; Pep Charusanti; Kerry L McPhail; Kristian Fog Nielsen; Lisa Vuong; Maryam Elfeki; Matthew F Traxler; Niclas Engene; Nobuhiro Koyama; Oliver B Vining; Ralph Baric; Ricardo R Silva; Samantha J Mascuch; Sophie Tomasi; Stefan Jenkins; Venkat Macherla; Thomas Hoffman; Vinayak Agarwal; Philip G Williams; Jingqui Dai; Ram Neupane; Joshua Gurr; Andrés M C Rodríguez; Anne Lamsa; Chen Zhang; Kathleen Dorrestein; Brendan M Duggan; Jehad Almaliti; Pierre-Marie Allard; Prasad Phapale; Louis-Felix Nothias; Theodore Alexandrov; Marc Litaudon; Jean-Luc Wolfender; Jennifer E Kyle; Thomas O Metz; Tyler Peryea; Dac-Trung Nguyen; Danielle VanLeer; Paul Shinn; Ajit Jadhav; Rolf Müller; Katrina M Waters; Wenyuan Shi; Xueting Liu; Lixin Zhang; Rob Knight; Paul R Jensen; Bernhard O Palsson; Kit Pogliano; Roger G Linington; Marcelino Gutiérrez; Norberto P Lopes; William H Gerwick; Bradley S Moore; Pieter C Dorrestein; Nuno Bandeira
Journal:  Nat Biotechnol       Date:  2016-08-09       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.